Patents by Inventor Anton G.T. Terwisscha Van Scheltinga

Anton G.T. Terwisscha Van Scheltinga has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10064963
    Abstract: The present disclosure relates to a method of treating, ameliorating or preventing a disorder by blocking the signaling pathway of c-Met, wherein said method comprises the step of administering a therapeutically effective amount of a composition to a subject in need thereof, which composition contains a lipocalin mutein or a fragment or a variant thereof. In addition, the present disclosure relates to a diagnostic composition suitable for use in, e.g., an immuno-imaging technique to detect the presence of c-Met as well as the uses thereof.
    Type: Grant
    Filed: January 7, 2013
    Date of Patent: September 4, 2018
    Assignee: PIERIS PHARMACEUTICALS GMBH
    Inventors: Shane Olwill, Hendrik Gille, Laurent Audoly, Marlon Hinner, Elisabeth De Vries, Anton G. T. Terwisscha Van Scheltinga
  • Publication number: 20150004098
    Abstract: The present disclosure relates to a method of treating, ameliorating or preventing a disorder by blocking the signaling pathway of c-Met, wherein said method comprises the step of administering a therapeutically effective amount of a composition to a subject in need thereof, which composition contains a lipocalin mutein or a fragment or a variant thereof. In addition, the present disclosure relates to a diagnostic composition suitable for use in, e.g., an immuno-imaging technique to detect the presence of c-Met as well as the uses thereof.
    Type: Application
    Filed: January 7, 2013
    Publication date: January 1, 2015
    Inventors: Shane Olwill, Hendrik Gille, Laurent Audoly, Marlon Hinner, Elisabeth De Vries, Anton G.T. Terwisscha Van Scheltinga